Imroatul Nasiyah
The core of this transformative technology lies in its remarkably small size and its capacity for extremely rapid data transfer. Developed through a synergistic collaboration between leading institutions – Columbia University, NewYork-Presbyterian Hospital, Stanford University, and the University of Pennsylvania – the device represents a significant leap forward in brain-computer interface (BCI) engineering. At its heart is a single silicon chip that establishes a wireless, high-bandwidth connection between the brain and external computing systems. This sophisticated system is aptly named the Biological Interface System to Cortex (BISC).
The intricate architecture of BISC is detailed in a seminal study published on December 8th in the esteemed journal Nature Electronics. The system comprises the chip-based implant itself, a wearable external "relay station," and the essential software infrastructure that orchestrates the platform’s operations. Professor Ken Shepard of Columbia University, a senior author and the driving force behind the engineering efforts, highlighted the stark contrast between BISC and existing implantable systems. "Most implantable systems are built around a canister of electronics that occupies enormous volumes of space inside the body," Professor Shepard explained. "Our implant is a single integrated circuit chip that is so thin that it can slide into the space between the brain and the skull, resting on the brain like a piece of wet tissue paper." This radical reduction in size and invasiveness is a key differentiator.
Professor Shepard’s close collaboration with Dr. Andreas S. Tolias, a senior and co-corresponding author from Stanford University’s Byers Eye Institute and co-founding director of the Enigma Project, was instrumental. Dr. Tolias’s extensive expertise in training artificial intelligence (AI) systems on large-scale neural recordings, including those acquired with BISC, provided crucial insights into the implant’s ability to decode brain activity. "BISC turns the cortical surface into an effective portal, delivering high-bandwidth, minimally invasive read-write communication with AI and external devices," Dr. Tolias stated. "Its single-chip scalability paves the way for adaptive neuroprosthetics and brain-AI interfaces to treat many neuropsychiatric disorders, such as epilepsy." This underscores the potential for BISC to serve as a foundational technology for future neuroprosthetic devices.
The clinical cornerstone of the project was provided by Dr. Brett Youngerman, an assistant professor of neurological surgery at Columbia University and a neurosurgeon at NewYork-Presbyterian/Columbia University Irving Medical Center. "This high-resolution, high-data-throughput device has the potential to revolutionize the management of neurological conditions from epilepsy to paralysis," Dr. Youngerman asserted. His clinical perspective was vital in shaping the development and application of BISC. Notably, Dr. Youngerman, Professor Shepard, and Dr. Catherine Schevon, an epilepsy neurologist at NewYork-Presbyterian/Columbia, have secured a National Institutes of Health grant to explore BISC’s application in treating drug-resistant epilepsy. "The key to effective brain-computer interface devices is to maximize the information flow to and from the brain, while making the device as minimally invasive in its surgical implantation as possible. BISC surpasses previous technology on both fronts," Dr. Youngerman added, emphasizing the dual advantages of BISC.
Professor Shepard further elaborated on the technological underpinnings, drawing parallels to the evolution of computing power. "Semiconductor technology has made this possible, allowing the computing power of room-sized computers to now fit in your pocket," he remarked. "We are now doing the same for medical implantables, allowing complex electronics to exist in the body while taking up almost no space." This analogy powerfully illustrates the miniaturization achieved by BISC.
The engineering behind BISC represents a significant departure from current BCI methodologies. Traditional medical-grade BCIs typically employ multiple discrete microelectronic components, such as amplifiers, data converters, and radio transmitters. These separate elements necessitate a relatively large implanted canister, often requiring skull removal or placement elsewhere in the body with connecting wires extending to the brain. In contrast, BISC integrates the entire system onto a single complementary metal-oxide-semiconductor (CMOS) integrated circuit. This chip has been meticulously thinned to a mere 50 micrometers, occupying less than 1/1000th the volume of conventional implants. With a total volume of approximately 3 cubic millimeters, the flexible chip is designed to conform to the intricate contours of the brain’s surface. This micro-electrocorticography (µECoG) device is equipped with an astonishing 65,536 electrodes, enabling 1,024 recording channels and 16,384 stimulation channels. The utilization of standard semiconductor industry manufacturing methods ensures its suitability for large-scale, cost-effective production.
Crucially, the BISC chip integrates a comprehensive suite of functionalities, including a radio transceiver, a wireless power circuit, digital control electronics, power management systems, data converters, and the analog components essential for both neural recording and stimulation. The external relay station serves as the communication hub, providing power and facilitating data exchange via a custom ultrawideband radio link. This link boasts an impressive data throughput of 100 megabits per second (Mbps), representing a performance increase of at least 100 times compared to any other wireless BCI currently available. Functioning as an 802.11 WiFi device, the relay station seamlessly bridges the implant to any compatible computer.
BISC also incorporates its own proprietary instruction set and a comprehensive software environment, effectively creating a specialized computing system tailored for brain interfaces. The high-bandwidth recording capabilities demonstrated in this study are pivotal, allowing brain signals to be processed by state-of-the-art machine-learning and deep-learning algorithms. These advanced algorithms are capable of deciphering complex neural patterns, enabling the interpretation of intricate intentions, perceptual experiences, and various brain states. "By integrating everything on one piece of silicon, we’ve shown how brain interfaces can become smaller, safer, and dramatically more powerful," Professor Shepard emphasized.
The advanced semiconductor fabrication process employed for the BISC implant is a testament to cutting-edge manufacturing. It utilizes TSMC’s 0.13-µm Bipolar-CMOS-DMOS (BCD) technology. This sophisticated fabrication method uniquely combines three distinct semiconductor technologies onto a single chip, enabling the creation of highly efficient mixed-signal integrated circuits (ICs). This integration allows for the seamless coexistence of digital logic (from CMOS), high-current and high-voltage analog functions (from bipolar and DMOS transistors), and power devices (from DMOS), all of which are critical for BISC’s exceptional performance.
The journey from laboratory innovation to clinical application is actively underway. Professor Shepard’s team has joined forces with Dr. Youngerman at NewYork-Presbyterian/Columbia University Irving Medical Center to facilitate the transition of BISC into real-world medical settings. They have successfully developed and refined surgical procedures for the safe placement of the ultra-thin implant in preclinical models, validating its ability to produce high-quality, stable neural recordings. Short-term intraoperative studies in human patients are already commencing.
"These initial studies give us invaluable data about how the device performs in a real surgical setting," Dr. Youngerman commented. "The implants can be inserted through a minimally invasive incision in the skull and slid directly onto the surface of the brain in the subdural space. The paper-thin form factor and lack of brain-penetrating electrodes or wires tethering the implant to the skull minimize tissue reactivity and signal degradation over time." This description highlights the clinical advantages of BISC’s design.
Extensive preclinical research, focusing on the motor and visual cortices, was conducted in collaboration with Dr. Tolias and Dr. Bijan Pesaran, a distinguished professor of neurosurgery at the University of Pennsylvania, both recognized leaders in computational and systems neuroscience. "The extreme miniaturization achieved by BISC is very exciting as a platform for new generations of implantable technologies that also interface with the brain with other modalities such as light and sound," Dr. Pesaran noted, pointing to future avenues of research and development.
The development of BISC was supported by the Defense Advanced Research Projects Agency (DARPA) through its Neural Engineering System Design program. The project leverages Columbia University’s profound expertise in microelectronics, the advanced neuroscience programs at Stanford and the University of Pennsylvania, and the exceptional surgical capabilities of NewYork-Presbyterian/Columbia University Irving Medical Center.
To accelerate the commercialization of this transformative technology, researchers from Columbia and Stanford have established Kampto Neurotech. This startup, founded by Dr. Nanyu Zeng, a Columbia electrical engineering alumnus and one of the project’s lead engineers, is currently producing research-ready versions of the BISC chip and actively seeking funding to prepare the system for human patient use. "This is a fundamentally different way of building BCI devices," Dr. Zeng stated. "In this way, BISC has technological capabilities that exceed those of competing devices by many orders of magnitude."
As artificial intelligence continues its rapid advancement, BCIs are gaining significant traction, not only for their potential to restore lost abilities in individuals with neurological disorders but also for future applications aimed at enhancing normal human function through direct brain-to-computer communication. "By combining ultra-high resolution neural recording with fully wireless operation, and pairing that with advanced decoding and stimulation algorithms, we are moving toward a future where the brain and AI systems can interact seamlessly — not just for research, but for human benefit," Professor Shepard concluded. "This could change how we treat brain disorders, how we interface with machines, and ultimately how humans engage with AI." The implications of BISC extend far beyond immediate medical applications, promising a profound reshaping of the human experience in an increasingly technologically integrated world.
